<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/300gg–8" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/300gg–8/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/300gg–8/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_300gg_8"><akn:num>300gg–8</akn:num><akn:heading>Coverage for individuals participating in approved clinical trials</akn:heading><akn:content><akn:p>§ 300gg–8. Coverage for individuals participating in approved clinical trials(a) Coverage(1) In generalIf a group health plan or a health insurance issuer offering group or individual health insurance coverage provides coverage to a qualified individual, then such plan or issuer—(A) may not deny the individual participation in the clinical trial referred to in subsection (b)(2);

(B) subject to subsection (c), may not deny (or limit or impose additional conditions on) the coverage of routine patient costs for items and services furnished in connection with participation in the trial; and

(C) may not discriminate against the individual on the basis of the individual’s participation in such trial.


(2) Routine patient costs(A) InclusionFor purposes of paragraph (1)(B), subject to subparagraph (B), routine patient costs include all items and services consistent with the coverage provided in the plan (or coverage) that is typically covered for a qualified individual who is not enrolled in a clinical trial.


(B) ExclusionFor purposes of paragraph (1)(B), routine patient costs does not include—(i) the investigational item, device, or service, itself;

(ii) items and services that are provided solely to satisfy data collection and analysis needs and that are not used in the direct clinical management of the patient; or

(iii) a service that is clearly inconsistent with widely accepted and established standards of care for a particular diagnosis.



(3) Use of in-network providersIf one or more participating providers is participating in a clinical trial, nothing in paragraph (1) shall be construed as preventing a plan or issuer from requiring that a qualified individual participate in the trial through such a participating provider if the provider will accept the individual as a participant in the trial.


(4) Use of out-of-networkNotwithstanding paragraph (3), paragraph (1) shall apply to a qualified individual participating in an approved clinical trial that is conduc</akn:p></akn:content><akn:subsection eId="subsec_300gg_8_a"><akn:num>(a)</akn:num><akn:heading>Coverage</akn:heading><akn:content><akn:p>(a) Coverage</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_b"><akn:num>(b)</akn:num><akn:heading>Qualified individual defined</akn:heading><akn:content><akn:p>(b) Qualified individual defined For purposes of subsection (a), the term “qualified individual” means an individual who is a participant or beneficiary in a health plan or with coverage described in subsection (a)(1) and who meets the following conditions:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_c"><akn:num>(c)</akn:num><akn:heading>Limitations on coverage</akn:heading><akn:content><akn:p>(c) Limitations on coverage This section shall not be construed to require a group health plan, or a health insurance issuer offering group or individual health insurance coverage, to provide benefits for routine patient care services provided outside of the plan’s (or coverage’s) health care provider network unless out-of-network benefits are otherwise provided under the plan (or coverage).</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_d"><akn:num>(d)</akn:num><akn:heading>Approved clinical trial defined</akn:heading><akn:content><akn:p>(d) Approved clinical trial defined</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_e"><akn:num>(e)</akn:num><akn:heading>Life-threatening condition defined</akn:heading><akn:content><akn:p>(e) Life-threatening condition defined In this section, the term “life-threatening condition” means any disease or condition from which the likelihood of death is probable unless the course of the disease or condition is interrupted.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_f"><akn:num>(f)</akn:num><akn:heading>Construction</akn:heading><akn:content><akn:p>(f) Construction Nothing in this section shall be construed to limit a plan’s or issuer’s coverage with respect to clinical trials.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_g"><akn:num>(g)</akn:num><akn:heading>Application to FEHBP</akn:heading><akn:content><akn:p>(g) Application to FEHBP Notwithstanding any provision of chapter 89 of title 5, this section shall apply to health plans offered under the program under such chapter.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300gg_8_h"><akn:num>(h)</akn:num><akn:heading>Preemption</akn:heading><akn:content><akn:p>(h) Preemption Notwithstanding any other provision of this chapter, nothing in this section shall preempt State laws that require a clinical trials policy for State regulated health insurance plans that is in addition to the policy required under this section..</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>